Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure

K. Konishi, H. Suzuki, T. Saruta, M. Hayashi, N. Deguchi, H. Tazaki, A. Hisaka

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The removal of imipenem and cilastatin by hemodialysis was studied in 14 (for imipenem) and 6 (for cilastatin) subjects. Following intravenous infusion of imipenem and cilastatin at a combined concentration of 10 mg/kg of body weight, drug levels in plasma were determined serially during off- and on-hemodialysis periods, which were 2 and 4 h, respectively. The biexponential decay of the drug levels in plasma was evident in each subject for both imipenem and cilastatin. Hemodialysis accelerated the elimination of both imipenem and cilastatin: the mean elimination-phase half-life of imipenem was shortened from 200 to 78 min, and that of cilastatin was shortened from 445 to 115 min. Hemodialysis clearance of imipenem and cilastatin was calculated by five different methods, each with intrinsic assumptions. The mean hemodialysis clearance of imipenem was estimated to be 74.08 ± 13.29 ml/min, and that of cilastatin was estimated to be 65.0 ± 8.6 ml/min, after consideration of various methodological limitations. It was estimated that in a hypothetical anephric patient weighing 60 kg, a 4-h hemodialysis treatment would remove 54.8% of the imipenem and 62.9% of the cilastatin present in the body at the start of dialysis.

Original languageEnglish
Pages (from-to)1616-1620
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume35
Issue number8
Publication statusPublished - 1991

Fingerprint

Chronic Kidney Failure
Renal Dialysis
Cilastatin
Imipenem
imipenem drug combination cilastatin
Intravenous Infusions
Pharmaceutical Preparations
Half-Life
Dialysis
Body Weight

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Konishi, K., Suzuki, H., Saruta, T., Hayashi, M., Deguchi, N., Tazaki, H., & Hisaka, A. (1991). Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure. Antimicrobial Agents and Chemotherapy, 35(8), 1616-1620.

Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure. / Konishi, K.; Suzuki, H.; Saruta, T.; Hayashi, M.; Deguchi, N.; Tazaki, H.; Hisaka, A.

In: Antimicrobial Agents and Chemotherapy, Vol. 35, No. 8, 1991, p. 1616-1620.

Research output: Contribution to journalArticle

Konishi, K, Suzuki, H, Saruta, T, Hayashi, M, Deguchi, N, Tazaki, H & Hisaka, A 1991, 'Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure', Antimicrobial Agents and Chemotherapy, vol. 35, no. 8, pp. 1616-1620.
Konishi K, Suzuki H, Saruta T, Hayashi M, Deguchi N, Tazaki H et al. Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure. Antimicrobial Agents and Chemotherapy. 1991;35(8):1616-1620.
Konishi, K. ; Suzuki, H. ; Saruta, T. ; Hayashi, M. ; Deguchi, N. ; Tazaki, H. ; Hisaka, A. / Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure. In: Antimicrobial Agents and Chemotherapy. 1991 ; Vol. 35, No. 8. pp. 1616-1620.
@article{2eb455b037454a0187f77d08ab1e6fcb,
title = "Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure",
abstract = "The removal of imipenem and cilastatin by hemodialysis was studied in 14 (for imipenem) and 6 (for cilastatin) subjects. Following intravenous infusion of imipenem and cilastatin at a combined concentration of 10 mg/kg of body weight, drug levels in plasma were determined serially during off- and on-hemodialysis periods, which were 2 and 4 h, respectively. The biexponential decay of the drug levels in plasma was evident in each subject for both imipenem and cilastatin. Hemodialysis accelerated the elimination of both imipenem and cilastatin: the mean elimination-phase half-life of imipenem was shortened from 200 to 78 min, and that of cilastatin was shortened from 445 to 115 min. Hemodialysis clearance of imipenem and cilastatin was calculated by five different methods, each with intrinsic assumptions. The mean hemodialysis clearance of imipenem was estimated to be 74.08 ± 13.29 ml/min, and that of cilastatin was estimated to be 65.0 ± 8.6 ml/min, after consideration of various methodological limitations. It was estimated that in a hypothetical anephric patient weighing 60 kg, a 4-h hemodialysis treatment would remove 54.8{\%} of the imipenem and 62.9{\%} of the cilastatin present in the body at the start of dialysis.",
author = "K. Konishi and H. Suzuki and T. Saruta and M. Hayashi and N. Deguchi and H. Tazaki and A. Hisaka",
year = "1991",
language = "English",
volume = "35",
pages = "1616--1620",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Removal of imipenem and cilastatin by hemodialysis in patients with end- stage renal failure

AU - Konishi, K.

AU - Suzuki, H.

AU - Saruta, T.

AU - Hayashi, M.

AU - Deguchi, N.

AU - Tazaki, H.

AU - Hisaka, A.

PY - 1991

Y1 - 1991

N2 - The removal of imipenem and cilastatin by hemodialysis was studied in 14 (for imipenem) and 6 (for cilastatin) subjects. Following intravenous infusion of imipenem and cilastatin at a combined concentration of 10 mg/kg of body weight, drug levels in plasma were determined serially during off- and on-hemodialysis periods, which were 2 and 4 h, respectively. The biexponential decay of the drug levels in plasma was evident in each subject for both imipenem and cilastatin. Hemodialysis accelerated the elimination of both imipenem and cilastatin: the mean elimination-phase half-life of imipenem was shortened from 200 to 78 min, and that of cilastatin was shortened from 445 to 115 min. Hemodialysis clearance of imipenem and cilastatin was calculated by five different methods, each with intrinsic assumptions. The mean hemodialysis clearance of imipenem was estimated to be 74.08 ± 13.29 ml/min, and that of cilastatin was estimated to be 65.0 ± 8.6 ml/min, after consideration of various methodological limitations. It was estimated that in a hypothetical anephric patient weighing 60 kg, a 4-h hemodialysis treatment would remove 54.8% of the imipenem and 62.9% of the cilastatin present in the body at the start of dialysis.

AB - The removal of imipenem and cilastatin by hemodialysis was studied in 14 (for imipenem) and 6 (for cilastatin) subjects. Following intravenous infusion of imipenem and cilastatin at a combined concentration of 10 mg/kg of body weight, drug levels in plasma were determined serially during off- and on-hemodialysis periods, which were 2 and 4 h, respectively. The biexponential decay of the drug levels in plasma was evident in each subject for both imipenem and cilastatin. Hemodialysis accelerated the elimination of both imipenem and cilastatin: the mean elimination-phase half-life of imipenem was shortened from 200 to 78 min, and that of cilastatin was shortened from 445 to 115 min. Hemodialysis clearance of imipenem and cilastatin was calculated by five different methods, each with intrinsic assumptions. The mean hemodialysis clearance of imipenem was estimated to be 74.08 ± 13.29 ml/min, and that of cilastatin was estimated to be 65.0 ± 8.6 ml/min, after consideration of various methodological limitations. It was estimated that in a hypothetical anephric patient weighing 60 kg, a 4-h hemodialysis treatment would remove 54.8% of the imipenem and 62.9% of the cilastatin present in the body at the start of dialysis.

UR - http://www.scopus.com/inward/record.url?scp=0025987788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025987788&partnerID=8YFLogxK

M3 - Article

C2 - 1929334

AN - SCOPUS:0025987788

VL - 35

SP - 1616

EP - 1620

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -